Hypomethylation of the PLAUR gene promoter has been linked to increased uPAR expression in cancers such as colorectal and breast cancers, where it correlates with enhanced metastatic potential and poor prognosis [272,273,274,275]. This evidence concerns the gene PLAUR and breast carcinoma.